Search

Author/Creator Yoshida, E. M.

1. Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa‐2b/ribavirin. Issue 1 (26th May 2013)

Authors:
Gordon, S. C.; Yoshida, E. M.; Lawitz, E. J.; Bacon, B. R.; Sulkowski, M. S.; Davis, M.; Poordad, F.; Bronowicki, J.‐P.; Esteban, R.; Sniukiene, V.; Burroughs, M. H.; Deng, W.; Dutko, F. J.; Brass, C. A.; Albrecht, J. K.; Rajender Reddy, K.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 38:Issue 1(2013)
Page Start:
16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Open‐label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1‐infected patients who failed placebo plus peginterferon and ribavirin. Issue 3 (17th November 2015)

Authors:
Foster, G. R.; Ferenci, P.; Asselah, T.; Mantry, P.; Dufour, J.‐F.; Bourlière, M.; Forton, D.; Maevskaya, M.; Wright, D.; Yoshida, E. M.; García‐Samaniego, J.; Oliveira, C.; Wright, M.; Warner, N.; Sha, N.; Quinson, A.‐M.; Stern, J. O.
Journal:
Journal of viral hepatitis
Issue:
Volume 23:Issue 3(2016)
Page Start:
227
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Shift in disparities in hepatitis C treatment from interferon to DAA era: A population‐based cohort study. Issue 8 (20th February 2017)

Authors:
Janjua, N. Z.; Islam, N.; Wong, J.; Yoshida, E. M.; Ramji, A.; Samji, H.; Butt, Z. A.; Chong, M.; Cook, D.; Alvarez, M.; Darvishian, M.; Tyndall, M.; Krajden, M.
Journal:
Journal of viral hepatitis
Issue:
Volume 24:Issue 8(2017)
Page Start:
624
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗